Candin

(Candida albicans Skin Test Antigen For Cellular Hypersensitivity)

The only FDA-approved delayed-type hypersensitivity (DTH) Candida albicans extract-based skin test antigen available to assess cell-mediated immunity.

CANDIN may be useful in evaluating patients suspected of having reduced cellular immune response (Anergy).

Safety Information for Candin

 

Learn More
spherusol

(Coccidioides immitis Spherule-Derived Skin Test Antigen)

The only FDA-approved skin test antigen to assess cell-mediated immunity to Coccidioides, the causative agent of Valley Fever (coccidioidomycosis). Commonly referred to as the “Valley Fever Skin Test”.

The use of SPHERUSOL to detect delayed-type hypersensitivity response in a general population with unknown exposure to Coccidioides has not been evaluated.

Persons with acute or disseminated coccidioidomycosis may not develop a delayed-type hypersensitivity response to SPHERUSOL.

Persons with immunodeficiency and a history of coccidioidomycosis may not develop a delayed-type hypersensitivity response to SPHERUSOL

Safety Information for Spherusol

Learn More

About Nielsen BioSciences


Nielsen BioSciences, Inc. is a privately-held, San Diego-based biopharmaceutical company focused on developing and commercializing biological products with wide-ranging applications of cell-mediated immune responses.